Connected Drug Delivery Devices Market: Will Western Europe be Able to Beat the Adoption Rate of North America in the Coming Years?: Global Industry Analysis & Opportunity Assessment (2015 - 2027)
- REP-GB-2755
- 2018-05-14
- Category: Healthcare, Pharmaceuticals and Medical devices
- 228 Pages
- Format:
The growing healthcare expenditure provides significant opportunities to hospitals and companies in generating higher revenues. According to the Organization for Economic Cooperation and Development (OECD), the spending on healthcare is estimated to reach US$ 10 trillion by 2020. The healthcare spending in most of the European countries is growing faster than their GDP. According to the U.S. government’s center for Medicare and Medicaid Services (CMS) the healthcare expenditure has risen approximately by 7% and is expected to cross US$ 2 trillion. The Congressional Budget Office states that if the growth in healthcare spending continues at this rate, the CMS spending and private health cost would increase approximately to 25% of the GDP.
For minimizing the healthcare costs and improve the quality of life, countries across the world are seeking to shift the place of care from healthcare facilities to wherever the patients happen to be during their normal day. Half of all the healthcare will take place outside the healthcare facilities within the decade. In many cases, the future of healthcare will be environments such as the home, workplace, school, café, or gym, with the patients responsible for the administration of their therapy. With the typical frequency for a self-injectable biologic ranging from one week to every month or quarter, devices that contain and deliver a drug must be highly intuitive. This trend will continue to accelerate over the next decade, as payers and providers will seek greater access to real-time, cloud-based data that can accurately assess how patients with a chronic disease adhere to their assigned drug regime.
North America will take the lead in the market in the long run with the maximum adoption
Significant focus on shifting to value-based reimbursement model are likely to reduce healthcare costs, which is over 17% of total GDP and health services financing sources witnessing an increase from private sources and decrease in public subsidies is expected to have a major impact on the
Health service providers increasingly collaborating with customers are expected to demonstrate clinical and financial benefit of services and the penetration of artificial intelligence technologies and big data analytics in health technologies, especially for real-time decision making to manage chronic diseases will pave way for future prospects for the market in North America in the near future. Vendors achieving economies of scale by leveraging large customer base and maintaining leading market position are expected to take the market forward in the long run. High geriatric population in the U.S. is anticipated to boost the demand for home healthcare and patient monitoring devices and services in the region and thus, augur well for the market growth in the region.
Western Europe is expected to closely follow North America in the coming years
Countries such as France, Germany, Italy, and Spain are expected to witness fluctuating demand for connected drug delivery devices in the coming years. France has high potential market but adoption of mobile health is average showing more reluctant to embrace digitalization of healthcare. The implementation of mobile health and related connected drug delivery devices is expected to present considerable challenges, including technological barriers, organizational challenges, confidentiality concerns and unplanned aftereffects. German consumers’ willingness to invest in their well-being and fast data networks is providing fertile ground for mHealth and connected drug delivery devices market growth. Health insurers in Germany have not yet introduced comprehensive reimbursement for m-health applications and connected drug delivery devices, any such strategic changes to acquire larger set of customer will be focused on younger, healthy consumers willing to pay for these services. This might adversely impact the market growth in the region.
Global Healthcare Sector Outlook in Light of the Global Connected Drug Delivery Devices Market
Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.
A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, blockchain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets.
Parent Indicators Healthcare
-
Current expenditure on health, % of gross domestic product
-
Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs)
-
Annual growth rate of current expenditure on health, per capita, in real terms
-
Out-of-pocket expenditure, % of current expenditure on health
-
Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs)
-
Physicians, Density per 1000 population (head counts)
-
Nurses, Density per 1000 population (head counts)
-
Total hospital beds, per 1000 population
-
Curative (acute) care beds, per 1000 population
-
Medical technology, Magnetic Resonance Imaging units, total, per million population
-
Medical technology, Computed Tomography scanners, total, per million population
Research Methodology
FMI utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, number of procedures and capital equipment install base to obtain precise market estimations and insights on various medical devices and medical technology. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.
Secondary research is used at the initial phase to identify the feasibility of the target products/technology categories and its respective segments, product offerings, usage pattern as per disease indications, product installed base in target healthcare facilities, life span of a device, reimbursement scenario, adoption rate and future impact of new technologies.
Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.
Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, and supply-side providers of medical devices who provide valuable insights on trends, key treatment patterns, adoption rate, and purchasing pattern, technological development of medical devices, patient education, effectiveness of manufacturers and important strategies, pricing and competitive dynamics.
Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.
On the other hand, we also analyse various companies annual reports, investor presentations, SEC filings, 10k reports and press release operating in this market segment to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at tier level based on their revenues, product portfolio and presence.
Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as per capita healthcare expenditure, disposable income, industry based demand driving factors impacting the market and its forecast trends apart from disease related factors.
Standard Report Structure
-
Executive Summary
-
Market Definition
-
Macro-economic analysis
-
Parent Market Analysis
-
Market Overview
-
Forecast Factors
-
Segmental Analysis and Forecast
-
Regional Analysis
-
Competition Analysis
Market Taxonomy
The global connected drug delivery devices market has been segmented into:
|
Region |
End User |
Product Type |
Technology |
Application |
|---|---|---|---|---|
|
|
|
|
|
Connected Drug Delivery Devices Market Reports - Table of Contents
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
2.3. Market Inclusion and Exclusion
3. Connected Drug Delivery Devices Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
3.3. Drivers
3.3.1. Supply Side Drivers
3.3.2. Demand Side Drivers
3.4. Restraints
3.5. Trends
4. Global Economic Outlook
4.1. Global Gross Domestic Product by Region & Country
4.2. Global Healthcare Market Indicator
5. North America Connected Drug Delivery Devices Market Analysis and Forecast 2015–2027
5.1. Introduction
5.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2027
5.2.1. U.S.
5.2.2. Canada
5.3. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2015-2027
5.3.1. Inhalation Devices
5.3.2. Injectable Devices
5.3.2.1. Handheld Injectable Devices
5.3.2.2. Wearable Injectable Devices
5.4. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2015-2017
5.4.1. Bluetooth
5.4.2. Near Field Communication
5.5. Market Size (US$ Mn) Forecast By Application, 2015-2027
5.5.1. Anaphylaxis
5.5.2. Cardiovascular
5.5.3. Diabetes
5.5.4. Hormone Replacement
5.5.5. Others
5.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2015-2027
5.6.1. Hospitals
5.6.2. Clinics
5.6.3. Homecare
5.7. Market Attractiveness Analysis
5.7.1. By Product Type
5.7.2. Technology
5.7.3. By Application
5.7.4. By End User
5.7.5. By Country
5.8. Drivers and Restraints: Impact Analysis
5.9. Key Market Participants – Intensity Mapping
6. Latin America Connected Drug Delivery Devices Market Analysis and Forecast 2015–2027
6.1. Introduction
6.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2027
6.2.1. Brazil
6.2.2. Mexico
6.2.3. Argentina
6.2.4. Rest of Latin America
6.3. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2015-2027
6.3.1. Inhalation Devices
6.3.2. Injectable Devices
6.3.2.1. Handheld Injectable Devices
6.3.2.2. Wearable Injectable Devices
6.4. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2015-2017
6.4.1. Bluetooth
6.4.2. Near Field Communication
6.5. Market Size (US$ Mn) Forecast By Application, 2015-2027
6.5.1. Anaphylaxis
6.5.2. Cardiovascular
6.5.3. Diabetes
6.5.4. Hormone Replacement
6.5.5. Others
6.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2015-2027
6.6.1. Hospitals
6.6.2. Clinics
6.6.3. Homecare
6.7. Market Attractiveness Analysis
6.7.1. By Product Type
6.7.2. Technology
6.7.3. By Application
6.7.4. By End User
6.7.5. By Country
6.8. Drivers and Restraints: Impact Analysis
6.9. Key Market Participants – Intensity Mapping
7. Western Europe Connected Drug Delivery Devices Market Analysis and Forecast 2015–2027
7.1. Introduction
7.2. Market Size (US$ Mn) Forecast By Country, 2015-2027
7.2.1. Germany
7.2.2. U.K
7.2.3. France
7.2.4. Italy
7.2.5. Spain
7.2.6. Rest of Western Europe
7.3. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2015-2027
7.3.1. Inhalation Devices
7.3.2. Injectable Devices
7.3.2.1. Handheld Injectable Devices
7.3.2.2. Wearable Injectable Devices
7.4. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2015-2017
7.4.1. Bluetooth
7.4.2. Near Field Communication
7.5. Market Size (US$ Mn) Forecast By Application, 2015-2027
7.5.1. Anaphylaxis
7.5.2. Cardiovascular
7.5.3. Diabetes
7.5.4. Hormone Replacement
7.5.5. Others
7.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2015-2027
7.6.1. Hospitals
7.6.2. Clinics
7.6.3. Homecare
7.7. Market Attractiveness Analysis
7.7.1. By Product Type
7.7.2. Technology
7.7.3. By Application
7.7.4. By End User
7.7.5. By Country
7.8. Drivers and Restraints: Impact Analysis
7.9. Key Market Participants – Intensity Mapping
8. Eastern Europe Connected Drug Delivery Devices Market Analysis and Forecast 2015–2027
8.1. Introduction
8.2. Market Size (US$ Mn) Forecast By Country, 2015-2027
8.2.1. Russia
8.2.2. Poland
8.2.3. Rest of Eastern Europe
8.3. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2015-2027
8.3.1. Inhalation Devices
8.3.2. Injectable Devices
8.3.2.1. Handheld Injectable Devices
8.3.2.2. Wearable Injectable Devices
8.4. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2015-2017
8.4.1. Bluetooth
8.4.2. Near Field Communication
8.5. Market Size (US$ Mn) Forecast By Application, 2015-2027
8.5.1. Anaphylaxis
8.5.2. Cardiovascular
8.5.3. Diabetes
8.5.4. Hormone Replacement
8.5.5. Others
8.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2015-2027
8.6.1. Hospitals
8.6.2. Clinics
8.6.3. Homecare
8.7. Market Attractiveness Analysis
8.7.1. By Product Type
8.7.2. Technology
8.7.3. By Application
8.7.4. By End User
8.7.5. By Country
8.8. Drivers and Restraints: Impact Analysis
8.9. Key Market Participants – Intensity Mapping
9. Asia Pacific Excluding China & Japan Connected Drug Delivery Devices Market Analysis and Forecast 2015–2027
9.1. Introduction
9.2. Market Size (US$ Mn) Forecast By Country, 2015-2027
9.2.1. India
9.2.2. Australia and New Zealand
9.2.3. ASEAN
9.2.4. Rest of APECJ
9.3. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2015-2027
9.3.1. Inhalation Devices
9.3.2. Injectable Devices
9.3.2.1. Handheld Injectable Devices
9.3.2.2. Wearable Injectable Devices
9.4. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2015-2017
9.4.1. Bluetooth
9.4.2. Near Field Communication
9.5. Market Size (US$ Mn) Forecast By Application, 2015-2027
9.5.1. Anaphylaxis
9.5.2. Cardiovascular
9.5.3. Diabetes
9.5.4. Hormone Replacement
9.5.5. Others
9.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2015-2027
9.6.1. Hospitals
9.6.2. Clinics
9.6.3. Homecare
9.7. Market Attractiveness Analysis
9.7.1. By Product Type
9.7.2. Technology
9.7.3. By Application
9.7.4. By End User
9.7.5. By Country
9.8. Drivers and Restraints: Impact Analysis
9.9. Key Market Participants – Intensity Mapping
10. China Connected Drug Delivery Devices Market Analysis and Forecast 2015–2027
10.1.Introduction
10.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2015-2027
10.2.1. Inhalation Devices
10.2.2. Injectable Devices
10.2.2.1. Handheld Injectable Devices
10.2.2.2. Wearable Injectable Devices
10.3. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2015-2017
10.3.1. Bluetooth
10.3.2. Near Field Communication
10.4. Market Size (US$ Mn) Forecast By Application, 2015-2027
10.4.1. Anaphylaxis
10.4.2. Cardiovascular
10.4.3. Diabetes
10.4.4. Hormone Replacement
10.4.5. Others
10.5. Historical Market Size (US$ Mn) Trend Analysis By End User, 2015-2027
10.5.1. Hospitals
10.5.2. Clinics
10.5.3. Homecare
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. Technology
10.6.3. By Application
10.6.4. By End User
10.7. Drivers and Restraints: Impact Analysis
10.8.Key Market Participants – Intensity Mapping
11. Japan Connected Drug Delivery Devices Market Analysis and Forecast 2015–2027
11.1.Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2015-2027
11.2.1. Inhalation Devices
11.2.2. Injectable Devices
11.2.2.1. Handheld Injectable Devices
11.2.2.2. Wearable Injectable Devices
11.3. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2015-2017
11.3.1. Bluetooth
11.3.2. Near Field Communication
11.4. Market Size (US$ Mn) Forecast By Application, 2015-2027
11.4.1. Anaphylaxis
11.4.2. Cardiovascular
11.4.3. Diabetes
11.4.4. Hormone Replacement
11.4.5. Others
11.5. Historical Market Size (US$ Mn) Trend Analysis By End User, 2015-2027
11.5.1. Hospitals
11.5.2. Clinics
11.5.3. Homecare
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. Technology
11.6.3. By Application
11.6.4. By End User
11.7. Drivers and Restraints: Impact Analysis
11.8. Key Market Participants – Intensity Mapping
12. Middle East and Africa Connected Drug Delivery Devices Market Analysis and Forecast 2015–2027
12.1. Introduction
12.2. Regional Market Trends
12.3. Market Size (US$ Mn) Forecast By Country, 2015-2027
12.3.1. GCC Countries
12.3.2. South Africa
12.3.3. Rest of Middle East and Africa
12.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2015-2027
12.4.1. Inhalation Devices
12.4.2. Injectable Devices
12.4.2.1. Handheld Injectable Devices
12.4.2.2. Wearable Injectable Devices
12.5. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2015-2017
12.5.1. Bluetooth
12.5.2. Near Field Communication
12.6. Market Size (US$ Mn) Forecast By Application, 2015-2027
12.6.1. Anaphylaxis
12.6.2. Cardiovascular
12.6.3. Diabetes
12.6.4. Hormone Replacement
12.6.5. Others
12.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2015-2027
12.7.1. Hospitals
12.7.2. Clinics
12.7.3. Homecare
12.8. Market Attractiveness Analysis
12.8.1. By Product Type
12.8.2. Technology
12.8.3. By Application
12.8.4. By End User
12.8.5. By Country
12.9. Drivers and Restraints: Impact Analysis
12.10. Key Market Participants – Intensity Mapping
13. Forecast Factors: Relevance and Impact
14. Forecast Assumptions
15. Market Structure Analysis
15.1.Market Structure by Tier
15.2.Market Share Analysis (2016) for Top Players, By Region
16. Competition Analysis
16.1.Competition Dashboard
16.2.Competitors Deep Dive
16.2.1. Bayer AG
16.2.1.1. Overview
16.2.1.2. Product and Application Portfolio
16.2.1.3. Production Footprint
16.2.1.4. Sales Footprint
16.2.1.5. Channel Footprint
16.2.1.6. Strategy
16.2.1.6.1. Marketing Strategy
16.2.1.6.2. Product Strategy
16.2.1.6.3. Channel Strategy
16.2.2. Propeller Health
16.2.2.1. Overview
16.2.2.2. Product and Application Portfolio
16.2.2.3. Production Footprint
16.2.2.4. Sales Footprint
16.2.2.5. Channel Footprint
16.2.2.6. Strategy
16.2.2.6.1. Marketing Strategy
16.2.2.6.2. Product Strategy
16.2.2.6.3. Channel Strategy
16.2.3. West Pharmaceutical Services, Inc.
16.2.3.1. Overview
16.2.3.2. Product and Application Portfolio
16.2.3.3. Production Footprint
16.2.3.4. Sales Footprint
16.2.3.5. Channel Footprint
16.2.3.6. Strategy
16.2.3.6.1. Marketing Strategy
16.2.3.6.2. Product Strategy
16.2.3.6.3. Channel Strategy
16.2.4. 3M Company
16.2.4.1. Overview
16.2.4.2. Product and Application Portfolio
16.2.4.3. Production Footprint
16.2.4.4. Sales Footprint
16.2.4.5. Channel Footprint
16.2.4.6. Strategy
16.2.4.6.1. Marketing Strategy
16.2.4.6.2. Product Strategy
16.2.4.6.3. Channel Strategy
16.2.5. OPKO Health
16.2.5.1. Overview
16.2.5.2. Product and Application Portfolio
16.2.5.3. Production Footprint
16.2.5.4. Sales Footprint
16.2.5.5. Channel Footprint
16.2.5.6. Strategy
16.2.5.6.1. Marketing Strategy
16.2.5.6.2. Product Strategy
16.2.5.6.3. Channel Strategy
16.2.6. Sagentia (Science Group)
16.2.6.1. Overview
16.2.6.2. Product and Application Portfolio
16.2.6.3. Production Footprint
16.2.6.4. Sales Footprint
16.2.6.5. Channel Footprint
16.2.6.6. Strategy
16.2.6.6.1. Marketing Strategy
16.2.6.6.2. Product Strategy
16.2.6.6.3. Channel Strategy
16.2.7. Cohero Health
16.2.7.1. Overview
16.2.7.2. Product and Application Portfolio
16.2.7.3. Production Footprint
16.2.7.4. Sales Footprint
16.2.7.5. Channel Footprint
16.2.7.6. Strategy
16.2.7.6.1. Marketing Strategy
16.2.7.6.2. Product Strategy
16.2.7.6.3. Channel Strategy
16.2.8. Care TRx
16.2.8.1. Overview
16.2.8.2. Product and Application Portfolio
16.2.8.3. Production Footprint
16.2.8.4. Sales Footprint
16.2.8.5. Channel Footprint
16.2.8.6. Strategy
16.2.8.6.1. Marketing Strategy
16.2.8.6.2. Product Strategy
16.2.8.6.3. Channel Strategy
16.2.9. CeQur SA
16.2.9.1. Overview
16.2.9.2. Product and Application Portfolio
16.2.9.3. Production Footprint
16.2.9.4. Sales Footprint
16.2.9.5. Channel Footprint
16.2.9.6. Strategy
16.2.9.6.1. Marketing Strategy
16.2.9.6.2. Product Strategy
16.2.9.6.3. Channel Strategy
16.2.10. Biocorp Production SA
16.2.10.1. Overview
16.2.10.2. Product and Application Portfolio
16.2.10.3. Production Footprint
16.2.10.4. Sales Footprint
16.2.10.5. Channel Footprint
16.2.10.6. Strategy
16.2.10.6.1. Marketing Strategy
16.2.10.6.2. Product Strategy
16.2.10.6.3. Channel Strategy
17. Global Connected Drug Delivery Devices Market Analysis Forecast 2015–2027, By Region
17.1. Introduction / Key Findings
17.2. Market Size (US$ Mn) Forecast By Region
17.2.1. North America
17.2.2. Western Europe
17.2.3. Eastern Europe
17.2.4. Latin America
17.2.5. Asia Pacific Excluding Japan And China
17.2.6. China
17.2.7. Japan
17.2.8. Middle East and Africa
17.3. Market Attractiveness Analysis By Region
18. Global Connected Drug Delivery Devices Market Analysis Forecast 2015–2027, By Product Type
18.1. Introduction/Key Finding
18.2. Market Size (US$ Mn) Forecast By Product Type, 2015-2027
18.2.1. Inhalation Devices
18.2.2. Injectable Devices
18.2.2.1. Handheld Injectable Devices
18.2.2.2. Wearable Injectable Devices
18.3. Market Attractiveness Analysis By Product Type
19. Global Connected Drug Delivery Devices Market Analysis Forecast 2015–2027, By Technology
19.1. Introduction/Key Finding
19.2. Market Size (US$ Mn) Forecast By Technology, 2015-2027
19.2.1. Bluetooth
19.2.2. Near Field Communication
19.3. Market Attractiveness Analysis By Technology
20. Global Connected Drug Delivery Devices Market Analysis Forecast 2015–2027, By Application
20.1. Introduction/Key Finding
20.2. Market Size (US$ Mn) Forecast By Application, 2015-2027
20.2.1. Anaphylaxis
20.2.2. Cardiovascular
20.2.3. Diabetes
20.2.4. Hormone Replacement
20.2.5. Others
20.3. Market Attractiveness Analysis By Application
21. Global Connected Drug Delivery Devices Market Analysis Forecast 2015–2027, By End User
21.1. Introduction/Key Finding
21.2.Market Size (US$ Mn) Forecast By End User, 2015-2027
21.2.1. Hospitals
21.2.2. Clinics
21.2.3. Homecare
21.3.Market Attractiveness Analysis By End User
22. Global Connected Drug Delivery Devices Market Analysis Forecast 2015–2027
22.1.Market Value Share Analysis By All Segment
22.2.Y-o-Y Growth Analysis By All Segment
22.3.Absolute $ Opportunity
23. Assumptions and Acronyms Used
24. Research Methodology
Connected Drug Delivery Devices Market Reports - List of Tables
Table 01: North America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Country
Table 02: North America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Product Type
Table 03: North America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Technology
Table 04: North America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Application
Table 05: North America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By End User
Table 06: Latin America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Country
Table 07: Latin America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Product Type
Table 08: Latin America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Technology
Table 09: Latin America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Application
Table 10: Latin America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By End User
Table 11: Western Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Country
Table 12: Western Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Product Type
Table 13: Western Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Technology
Table 14: Western Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Application
Table 15: Western Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By End User
Table 16: Eastern Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Country
Table 17: Eastern Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Product Type
Table 18: Eastern Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Technology
Table 19: Eastern Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Application
Table 20: Eastern Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By End User
Table 21: APECJ Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Country
Table 22: APECJ Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Product Type
Table 23: APECJ Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Technology
Table 24: APECJ Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Application
Table 25: APECJ Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By End User
Table 26: China Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Product Type
Table 27: China Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Technology
Table 28: China Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Application
Table 29: China Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By End User
Table 30: Japan Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Product Type
Table 31: Japan Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Technology
Table 32: Japan Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Application
Table 33: Japan Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By End User
Table 34: MEA Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Country
Table 35: MEA Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Product Type
Table 36: MEA Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Technology
Table 37: MEA Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Application
Table 38: MEA Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By End User
Table 39: Global Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Region
Table 40: Global Connected Drug Delivery Devices Market Value (US$ Mn) Analysis- and Opportunity Assessment 2015–2027, By Product Type
Table 41: Global Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2027, By Technology
Table 42: Global Connected Drug Delivery Devices Market Value (US$ Mn) Analysis- and Opportunity Assessment 2015–2027, By Application
Table 43: Global Connected Drug Delivery Devices Market Value (US$ Mn) Analysis-and Opportunity Assessment 2015–2027, By End User
Connected Drug Delivery Devices Market Reports - List of Figures
Figure 01: North America Connected Drug Delivery Devices Market Value Share By Product Type (2017 E)
Figure 02: North America Connected Drug Delivery Devices Market Value Share By Technology (2017 E)
Figure 03: North America Connected Drug Delivery Devices Market Value Share By Application (2017 E)
Figure 03: North America Connected Drug Delivery Devices Market Value Share By Country (2017 E)
Figure 04: North America Connected Drug Delivery Devices Market Value Share By End User (2017 E)
Figure 06: North America Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2015-2027
Figure 07: U.S. Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027
Figure 08: Canada Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027
Figure 08: Western Europe Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2015-2027
Figure 09: North America Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2017-2027
Figure 10: North America Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2017-2027
Figure 11: North America Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2017-2027
Figure 12: North America Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2017-2027
Figure 13: North America Connected Drug Delivery Devices Market Attractiveness Analysis by Country, 2017-2027
Figure 14: Latin America Connected Drug Delivery Devices Market Value Share By Product Type (2017 E)
Figure 15: Latin America Connected Drug Delivery Devices Market Value Share By Technology (2017 E)
Figure 16: Latin America Connected Drug Delivery Devices Market Value Share By Application (2017 E)
Figure 17: Latin America Connected Drug Delivery Devices Market Value Share By End User (2017 E)
Figure 18: Latin America Connected Drug Delivery Devices Market Value Share By Country (2017 E)
Figure 19: Latin America Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2015-2027
Figure 20: Brazil Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027
Figure 21: Mexico Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027
Figure 22: Argentina Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027
Figure 23: Rest of Latin America Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027
Figure 24: Latin America Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2017-2027
Figure 25: Latin America Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2017-2027
Figure 26: Latin America Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2017-2027
Figure 27: Latin America Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2017-2027
Figure 28: Latin America Connected Drug Delivery Devices Market Attractiveness Analysis by Country, 2017-2027
Figure 29: Western Europe Connected Drug Delivery Devices Market Value Share By Product Type (2017 E)
Figure 30: Western Europe Connected Drug Delivery Devices Market Value Share By Technology (2017 E)
Figure 31: Western Europe Connected Drug Delivery Devices Market Value Share By Application (2017 E)
Figure 32: Western Europe Connected Drug Delivery Devices Market Value Share By End User (2017 E)
Figure 33: Western Europe Connected Drug Delivery Devices Market Value Share By Country (2017 E)
Figure 34: U.K. Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027
Figure 35: Germany Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027
Figure 36: France Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027
Figure 37: Italy Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027
Figure 38: Spain Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027
Figure 39: Rest of Western Europe Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027
Figure 40: Western Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2017-2027
Figure 41: Western Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2017-2027
Figure 42: Western Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2017-2027
Figure 43: Western Europe Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2017-2027
Figure 44: Western Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Country, 2017-2027
Figure 45: Eastern Europe Connected Drug Delivery Devices Market Value Share By Product Type (2017 E)
Figure 46: Eastern Europe Connected Drug Delivery Devices Market Value Share By Technology (2017 E)
Figure 47: Eastern Europe Connected Drug Delivery Devices Market Value Share By Application (2017 E)
Figure 48: Eastern Europe Connected Drug Delivery Devices Market Value Share By End User (2017 E)
Figure 49: Eastern Europe Connected Drug Delivery Devices Market Value Share By Country (2017 E)
Figure 50: Eastern Europe Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2015-2027
Figure 51: Russia Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027
Figure 52: Poland Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027
Figure 53: Rest of Eastern Europe Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027
Figure 54: Eastern Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2017-2027
Figure 55: Eastern Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2017-2027
Figure 56: Eastern Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2017-2027
Figure 57: Eastern Europe Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2017-2027
Figure 58 : Eastern Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Country, 2017-2027
Figure 59: APECJ Connected Drug Delivery Devices Market Value Share By Product Type (2017 E)
Figure 60: APECJ Connected Drug Delivery Devices Market Value Share By Technology (2017 E)
Figure 61: APECJ Connected Drug Delivery Devices Market Value Share By Application (2017 E)
Figure 62: APECJ Connected Drug Delivery Devices Market Value Share By End User (2017 E)
Figure 63: APECJ Connected Drug Delivery Devices Market Value Share By Country (2017 E)
Figure 64: APECJ Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2015-2027
Figure 65: India Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027
Figure 66: ANZ Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027
Figure 67: ASEAN Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027
Figure 68: Rest of APECJ Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027
Figure 69: APECJ Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2017-2027
Figure 70: APECJ Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2017-2027
Figure 71: APECJ Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2017-2027
Figure 72: APECJ Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2017-2027
Figure 73: APECJ Connected Drug Delivery Devices Market Attractiveness Analysis by Country, 2017-2027
Figure 74: China Connected Drug Delivery Devices Market Value Share By Product Type (2017 E)
Figure 75: China Connected Drug Delivery Devices Market Value Share By Technology (2017 E)
Figure 76: China Connected Drug Delivery Devices Market Value Share By Application (2017 E)
Figure 77: China Connected Drug Delivery Devices Market Value Share By End User (2017 E)
Figure 78: China Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2015-2027
Figure 79: China Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2017-2027
Figure 80: China Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2017-2027
Figure 81: China Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2017-2027
Figure 82: China Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2017-2027
Figure 83: Japan Connected Drug Delivery Devices Market Value Share By Product Type (2017 E)
Figure 84: Japan Connected Drug Delivery Devices Market Value Share By Technology (2017 E)
Figure 85: Japan Connected Drug Delivery Devices Market Value Share By Application (2017 E)
Figure 86: Japan Connected Drug Delivery Devices Market Value Share By End User (2017 E)
Figure 87: Japan Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2015-2027
Figure 88: Japan Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2017-2027
Figure 89: Japan Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2017-2027
Figure 90: Japan Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2017-2027
Figure 91: Japan Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2017-2027
Figure 91: MEA Connected Drug Delivery Devices Market Value Share By Product Type (2017 E)
Figure 92: MEA Connected Drug Delivery Devices Market Value Share By Technology (2017 E)
Figure 93: MEA Connected Drug Delivery Devices Market Value Share By Country (2017 E)
Figure 94: MEA Connected Drug Delivery Devices Market Value Share By Application (2017 E)
Figure 95: MEA Connected Drug Delivery Devices Market Value Share By End User (2017 E)
Figure 96: MEA Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2015-2027
Figure 97: South Africa Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027
Figure 98: GCC Countries Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027
Figure 100: Rest of MEA Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027
Figure 101: MEA Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2017-2027
Figure 102: MEA Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2017-2027
Figure 103: MEA Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2017-2027
Figure 104: MEA Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2017-2027
Figure 105: MEA Connected Drug Delivery Devices Market Attractiveness Analysis by Country, 2017-2027
Figure 106: Global Connected Drug Delivery Devices Market Attractiveness Analysis by Region, 2017-2027
Figure 107: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By Inhalation Devices
Figure 108: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By Injectable Devices
Figure 109: Global Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2017-2027
Figure 110: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By Bluetooth
Figure 111: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By NFC
Figure 112: Global Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2017-2027
Figure 113: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By Anaphylaxis
Figure 114: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By Cardiovascular
Figure 115: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By Diabetes
Figure 116: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By Hormone Replacement
Figure 117: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By Others
Figure 118: Global Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2017-2027
Figure 119: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By Hospitals
Figure 120: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By Clinics
Figure 121: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015–2027, By Homecare
Figure 122: Global Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2017-2027
Figure 123: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2015-2027
Figure 124: Global Connected Drug Delivery Devices Market Absolute $ Opportunity, 2017 - 2027